ER− breast cancer is associated with elevated NF-κB activity [32,63], and shows increased expression of certain cytokines (IL-6, IL-8) and chemokines (CCL5, MCP-1 [CCL2]) [64,65]. This evidence concerns the gene CCL2 and breast cancer.